tetano
Editor, Senior Moderator
Phytomedicine
. 2020 Dec 4;81:153433.
doi: 10.1016/j.phymed.2020.153433. Online ahead of print.
Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study
Xin-Yu Ji[SUP] 1 [/SUP], Yan Ma[SUP] 1 [/SUP], Nan-Nan Shi[SUP] 1 [/SUP], Ning Liang[SUP] 1 [/SUP], Ren-Bo Chen[SUP] 1 [/SUP], Si-Hong Liu[SUP] 2 [/SUP], Shuai Shi[SUP] 3 [/SUP], Gui-Hui Wu[SUP] 4 [/SUP], Ji-Ke Li[SUP] 5 [/SUP], Hong Chen[SUP] 6 [/SUP], Jing-Wei Wang[SUP] 7 [/SUP], Hui Na[SUP] 7 [/SUP], Ying-Chun Zhou[SUP] 8 [/SUP], Min-Qing Li[SUP] 9 [/SUP], Yu-Dong Wang[SUP] 10 [/SUP], Xiao-Mei Hu[SUP] 11 [/SUP], Yun-Hong Hu[SUP] 12 [/SUP], Zhang Liu[SUP] 13 [/SUP], Hai-Jun Xie[SUP] 14 [/SUP], Lin-Song Zhang[SUP] 15 [/SUP], Hua-Min Zhang[SUP] 16 [/SUP], Yan-Ping Wang[SUP] 17 [/SUP], Yong-Yan Wang[SUP] 18 [/SUP]
Affiliations
Abstract
Objective: Previous studies mainly reported the clinical characteristics of novel coronavirus 2019 (COVID-19) infections, but the research on clinical characteristics and treatment outcomes of COVID-19 patients with stroke is still rare.
Methods: A multi-center retrospective study was conducted at 11 hospitals in 4 provinces of China, and COVID-19 patients with stroke were enrolled from February 24 to May 4, 2020. We analyzed epidemiological, demographic, and clinical characteristics of cases as well as the laboratory test results, treatment regimens and outcomes, and the clinical characteristics and therapeutic outcomes were compared between severe and nonsevere patients, and by age group, respectively.
Results: A total of 27 patients [mean age: 66.41 (SD 12.1) years] were enrolled. Among them, 9 (33.3%) were severe patients and 18 (66.7%) were nonsevere patients; 17 (63.0%) were female; 19 (70.4%) were aged 60 years and above. The most common symptoms were fever [19 (70.4%)], fatigue [12 (44.4%)] and cough [11 (40.7%)], respectively. Abnormal laboratory findings of COVID-19 patients with stroke included high levels of C-reactive protein [19 (73.1%)], D-dimer [14 (58.3%)], blood glucose [14 (53.8%)], fibrinogen [13 (50.0%)], and decreased lymphocytes [12 (44.4%)]. Comparing to nonsevere cases with stroke, severe patients with stroke were likely to be older, susceptible to receiving oxygen inhalation, and had more complications (p < 0.05). In addition, there were significant differences in lymphocytes, neutrophils, lactate dehydrogenase, C-reactive protein, creatine kinase between the severe cases and nonsevere cases (p < 0.05). The older patients had a decreased platelet count and elevated fibrinogen, compared with the younger (p < 0.05). All patients (100%) received antiviral treatment, 12 (44.4%) received antibiotics treatment, 26 (96.3%) received Traditional Chinese Medicine (Lung cleansing & detoxifying decoction), and oxygen inhalation was in 18 (66.7%). The median duration of hospitalization was 16 days. By May 4, 2020, a total of 26 (96.3%) patients were cured and discharged, and 1 (3.7%) patients died.
Conclusion: COVID-19 patients with stroke had poor indicators of coagulation system, and severe and older patients might have a higher risk of complications and unfavorable coagulation system. However, the overall treatment outcome is favorable.
Keywords: COVID-19; Clinical characteristics; Stroke; Treatment outcome.
. 2020 Dec 4;81:153433.
doi: 10.1016/j.phymed.2020.153433. Online ahead of print.
Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study
Xin-Yu Ji[SUP] 1 [/SUP], Yan Ma[SUP] 1 [/SUP], Nan-Nan Shi[SUP] 1 [/SUP], Ning Liang[SUP] 1 [/SUP], Ren-Bo Chen[SUP] 1 [/SUP], Si-Hong Liu[SUP] 2 [/SUP], Shuai Shi[SUP] 3 [/SUP], Gui-Hui Wu[SUP] 4 [/SUP], Ji-Ke Li[SUP] 5 [/SUP], Hong Chen[SUP] 6 [/SUP], Jing-Wei Wang[SUP] 7 [/SUP], Hui Na[SUP] 7 [/SUP], Ying-Chun Zhou[SUP] 8 [/SUP], Min-Qing Li[SUP] 9 [/SUP], Yu-Dong Wang[SUP] 10 [/SUP], Xiao-Mei Hu[SUP] 11 [/SUP], Yun-Hong Hu[SUP] 12 [/SUP], Zhang Liu[SUP] 13 [/SUP], Hai-Jun Xie[SUP] 14 [/SUP], Lin-Song Zhang[SUP] 15 [/SUP], Hua-Min Zhang[SUP] 16 [/SUP], Yan-Ping Wang[SUP] 17 [/SUP], Yong-Yan Wang[SUP] 18 [/SUP]
Affiliations
- PMID: 33373925
- DOI: 10.1016/j.phymed.2020.153433
Abstract
Objective: Previous studies mainly reported the clinical characteristics of novel coronavirus 2019 (COVID-19) infections, but the research on clinical characteristics and treatment outcomes of COVID-19 patients with stroke is still rare.
Methods: A multi-center retrospective study was conducted at 11 hospitals in 4 provinces of China, and COVID-19 patients with stroke were enrolled from February 24 to May 4, 2020. We analyzed epidemiological, demographic, and clinical characteristics of cases as well as the laboratory test results, treatment regimens and outcomes, and the clinical characteristics and therapeutic outcomes were compared between severe and nonsevere patients, and by age group, respectively.
Results: A total of 27 patients [mean age: 66.41 (SD 12.1) years] were enrolled. Among them, 9 (33.3%) were severe patients and 18 (66.7%) were nonsevere patients; 17 (63.0%) were female; 19 (70.4%) were aged 60 years and above. The most common symptoms were fever [19 (70.4%)], fatigue [12 (44.4%)] and cough [11 (40.7%)], respectively. Abnormal laboratory findings of COVID-19 patients with stroke included high levels of C-reactive protein [19 (73.1%)], D-dimer [14 (58.3%)], blood glucose [14 (53.8%)], fibrinogen [13 (50.0%)], and decreased lymphocytes [12 (44.4%)]. Comparing to nonsevere cases with stroke, severe patients with stroke were likely to be older, susceptible to receiving oxygen inhalation, and had more complications (p < 0.05). In addition, there were significant differences in lymphocytes, neutrophils, lactate dehydrogenase, C-reactive protein, creatine kinase between the severe cases and nonsevere cases (p < 0.05). The older patients had a decreased platelet count and elevated fibrinogen, compared with the younger (p < 0.05). All patients (100%) received antiviral treatment, 12 (44.4%) received antibiotics treatment, 26 (96.3%) received Traditional Chinese Medicine (Lung cleansing & detoxifying decoction), and oxygen inhalation was in 18 (66.7%). The median duration of hospitalization was 16 days. By May 4, 2020, a total of 26 (96.3%) patients were cured and discharged, and 1 (3.7%) patients died.
Conclusion: COVID-19 patients with stroke had poor indicators of coagulation system, and severe and older patients might have a higher risk of complications and unfavorable coagulation system. However, the overall treatment outcome is favorable.
Keywords: COVID-19; Clinical characteristics; Stroke; Treatment outcome.